Results 41 to 50 of about 2,066,293 (256)
BMC Infectious Diseases, 2023 Background Data for latent tuberculosis in patients with type 1 Diabetes in Africa is limited. We assessed the prevalence of latent tuberculosis in youth and children with type 1 Diabetes in Dar es Salaam –Tanzania.
Edna S. Majaliwa +6 more
doaj +1 more source
BMC Infectious Diseases, 2017 Background Healthcare workers in high tuberculosis burdened countries are occupationally exposed to the tuberculosis disease with uncomplicated and complicated tuberculosis on the increase among them.
Celso Belo, Saloshni Naidoo
doaj +1 more source
BMC Infectious Diseases, 2021 Objective To determine the prevalence of Latent Tuberculosis in patients with hematological neoplasms at the Instituto Nacional de Cancerología in Mexico City using the Tuberculin skin test (TST).
Erick Antonio Osorio-López +3 more
doaj +1 more source
Latent tuberculosis infection among medical students in Malaysia
Asian Pacific Journal of Tropical Medicine, 2019 Objective: This study aimed to determine prevalence of latent tuberculosis infection among medical students and tuberculosis exposure at the health facilities.
Maha Abdullah +7 more
doaj +1 more source
Dynamical aspects of a tuberculosis transmission model incorporating vaccination and time delay
Alexandria Engineering Journal, 2023 To explore transmission dynamics of tuberculosis, a tuberculosis transmission model with vaccination and time delay is developed in current paper. Positivity and boundedness are analyzed. Local stability of tuberculosis-free equilibrium in respect of the
Zizhen Zhang +5 more
doaj +1 more source
Diagnosis for Latent Tuberculosis Infection: New Alternatives
Frontiers in Immunology, 2020 Latent tuberculosis infection (LTBI) is a subclinical mycobacterial infection defined on the basis of cellular immune response to mycobacterial antigens.
C. Carranza +3 more
semanticscholar +1 more source
PLoS ONE, 2022 BackgroundTuberculosis remains a major public health problem worldwide accounting for 1.4 million deaths annually. LL-37 is an effector molecule involved in immunity with both antimicrobial and immunomodulatory properties.
Ester Lilian Acen +6 more
doaj +1 more source
Latent tuberculosis infection in the Polish prison staff
Medycyna Pracy, 2021 Background Tuberculosis is a chronic infectious disease caused by acid-fast mycobacteria from the Mycobacterium tuberculosis complex group. The disease spreads when people with pulmonary tuberculosis excrete bacteria when they cough, sneeze, laugh or ...
Aneta Filipek-Czerska +2 more
doaj +1 more source
The global prevalence of latent tuberculosis: a systematic review and meta-analysis
European Respiratory Journal, 2019 In 1999, the World Health Organization (WHO) estimated that one-third of the world's population had latent tuberculosis infection (LTBI), which was recently updated to one-fourth.
Adam Cohen +3 more
semanticscholar +1 more source
Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity
medRxiv, 2020 Importance: Risk factors associated with COVID-19, the viral pneumonia originating in Wuhan, China, in Dec 2019, require clarification so that medical resources can be prioritized for those at highest risk of severe COVID-19 complications. Infection with
Yong-Yu Liu +10 more
semanticscholar +1 more source